---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-034149"
form_type: "8-K"
ticker: "SNWV"
cik: "0001417663"
company_name: "SANUWAVE Health, Inc."
filed_at: "2026-05-12T20:33:51+00:00"
generated_at: "2026-05-12T20:35:45.356735+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Sanuwave Q1 rev $9.6M (+3.1% YoY); net loss $1.4M; guides Q2 growth 10-15%

## Summary
- Q1 revenue $9.6M, up 3.1% from $9.3M YoY; gross margin 77.3% vs 79.0%.
- GAAP operating loss $1.1M, a $1.7M swing from $0.6M operating income YoY.
- Ultramist consumables revenue $6.7M, up 15% YoY; set new all-time unit volume record.
- Adjusted EBITDA $1.1M vs $2.3M YoY; net loss $1.4M, improved from $6.1M loss (prior year had $4.9M non-cash derivative loss).
- Guides Q2 2026 revenue $11.1-11.6M (10-15% growth); reaffirms FY 2026 revenue $51-55M (16-25% growth).

## SEC filing metadata
- accession: 0001628280-26-034149
- form_type: 8-K
- ticker: SNWV
- cik: 0001417663
- company_name: SANUWAVE Health, Inc.
- filed_at: 2026-05-12T20:33:51+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417663/000162828026034149/0001628280-26-034149-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417663/000162828026034149/snwv-20260512.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-034149
- JSON: https://secwatch.observer/filing/0001628280-26-034149.json
- Plain text: https://secwatch.observer/filing/0001628280-26-034149.txt

## Key facts
- Earnings Releases
  SANUWAVE Health, Inc. reported the three months ended March 31, 2026 results: revenue $9.6 million. Guidance reaffirmed.
  - Period: the three months ended March 31, 2026
  - Revenue: $9.6 million
  - Guidance: reaffirmed
  - Result: reported results
  source text: Q1 2026 revenues were $9.6 million, up 3.1% from $9.3 million in Q1 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417663/000162828026034149/0001628280-26-034149-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.